Companies can update their own news on the directory by subscribing to a profile. Also your company profile and news can receive priority placing in results by subscribing to a premium profile. For further details on premium profiles please contact us at email@example.com
Hovione - 28 Sep 2020
Hovione is a Pharmaceutical Company dedicated to helping Pharmaceutical Customers bring new and off-patent drugs to market.
We do well what is difficult, to give our customers what they cannot find elsewhere.
Almac Group - 28 Sep 2020
Almac Group provides the most comprehensive range of services extending from research through pharmaceutical and clinical development to commercialisation of product.
Over 600 companies worldwide, including all the market leaders, use our services, testament itself to the quality, innovation and efficiency of our business as proven over the past 30 years.
Europital - 28 Sep 2020
Since 2010, the Europital team has been working hand-in-hand with our clients on a variety of global projects. These projects have been in a variety of Therapeutic Areas including Oncology, Infectious Diseases, Inflammatory Diseases, Immunology, Cardiology and Respiratory Diseases among others. Our experience spans from FIH studies, both in patients and healthy volunteers to large, Pivotal, international studies conducted across different continents
Samsung Biologics - 24 Sep 2020
Samsung Biologics is a world-class Contract Development and Manufacturing Organization (CDMO) committed to quality-driven development and manufacturing of biopharmaceutical products. Our customer-oriented business model supports both collaborative novel drug development and high-quality, fast-turnaround contract manufacturing partnerships. Our cutting edge facility was constructed to be compliant with global cGMP regulations. We will provide the infrastructure for partnerships…
Open Orphan - 24 Sep 2020
Open Orphan was founded in 2017, with the goal of becoming Europe’s leading rare disease and orphan drug focused pharma services company by a management team with extensive industry and financial expertise. Open Orphan is listed on both the London and Dublin stock exchanges.
Waisman Biomanufacturing - 16 Sep 2020
The primary mission of Waisman Biomanufacturing is to deliver efficient translation of scientific discoveries for early stage clinical trials by developing manufacturing processes and quality control methods in conjunction with providing overall product development and regulatory support. Our goal is to accelerate the advancement of novel biological therapies and vaccines by offering the manufacturing and support services required for cGMP production of drugs used in human clinical trials. Waisman…
Goodwin Biotechnology, Inc. - 16 Sep 2020
We offer a unique and unrivalled expertise in the research, development, validation and multi-gram manufacture of Antibody Drug Conjugates (ADCs), radioimmunoconjugates, and other protein bioconjugates. We have more than a decade of experience and multiple patents pending in protein modifications through chemical bioconjugation of cancer drugs, protein toxins, bifunctional ligands and metal chelates (for radio-isotope labeling), antibodies and other biological molecules onto monoclonal…
Binex - 09 Sep 2020
Since being founded in 1957 with the name SoonCheonDang, Binex has been committed to providing sustainable solutions to the healthcare challenges in Korea. Continuous innovation has been central in our efforts to solve the challenges in the industry, and we will strive to become a world-wide company through our continuous efforts.
After recognizing a paradigm shift toward biological drugs, we embarked on a new program to develop immune cell therapies targeting cancers.…